Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study

BACKGROUND: Ten-valent pneumococcal conjugate vaccine (PCV10), delivered at 6, 10, and 14 weeks of age was introduced in Kenya in January, 2011, accompanied by a catch-up campaign in Kilifi County for children aged younger than 5 years. Coverage with at least two PCV10 doses in children aged 2–11 mo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet
Main Authors: Hammitt, Laura L, Etyang, Anthony O, Morpeth, Susan C, Ojal, John, Mutuku, Alex, Mturi, Neema, Moisi, Jennifer C, Adetifa, Ifedayo M, Karani, Angela, Akech, Donald O, Otiende, Mark, Bwanaali, Tahreni, Wafula, Jackline, Mataza, Christine, Mumbo, Edward, Tabu, Collins, Knoll, Maria Deloria, Bauni, Evasius, Marsh, Kevin, Williams, Thomas N, Kamau, Tatu, Sharif, Shahnaaz K, Levine, Orin S, Scott, J Anthony G
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6548991/
https://ncbi.nlm.nih.gov/pubmed/31000194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(18)33005-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados